This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Dow (DOW) to Build Net-Zero Carbon Emissions Ethylene Cracker
by Zacks Equity Research
The project is in sync with Dow's (DOW) broader goals to achieve carbon neutrality by 2050 and eliminate plastic waste in the environment.
Celanese (CE) Announces Price Rise for Acetate Tow
by Zacks Equity Research
Celanese's (CE) major production costs skyrocket in response to sector demand, conversions and availability, leading to price hike.
Should You Invest in the First Trust Materials AlphaDEX ETF (FXZ)?
by Zacks Equity Research
Sector ETF report for FXZ
Eastman Chemical (EMN) Benefits on Cost Actions and Innovation
by Zacks Equity Research
Eastman Chemical (EMN) gains on cost-cutting and productivity actions and efforts to drive new business revenues from innovation.
DOW Introduces Dowsil Coating for Better PCB Protection
by Zacks Equity Research
Dow Inc. (DOW) unveils a silicone-based protective coating to better serve customers in the manufacturing and assembly line of PCBs.
PPG Industries (PPG) Gets EPA Registration for Copper Armor Paint
by Zacks Equity Research
PPG Industries' (PPG) paint consists of the Corning Guardiant technology, proven to kill 99.9% of bacteria and viruses on the painted surface, including SARS-CoV-2, in two hours.
Here's Why You Should Invest in Celanese (CE) Stock Now
by Zacks Equity Research
Celanese (CE) benefits from its productivity actions, investments in high-return projects, demand recovery and strategic acquisitions.
Zacks.com featured highlights include: T. Rowe Price, Best Buy, Celanese Corp, CBRE Group and Regeneron Pharma
by Zacks Equity Research
Zacks.com featured highlights include: T. Rowe Price, Best Buy, Celanese Corp, CBRE Group and Regeneron Pharma
5 High ROE Stocks to Buy as Markets Face Intense Volatility
by Supriyo Bose
T. Rowe Price Group (TROW), Best Buy (BBY), Celanese Corporation (CE), CBRE Group (CBRE), and Regeneron Pharmaceuticals (REGN) are some of the stocks with high ROE to buy in a volatile market.
Celanese (CE) Unveils Hostaform RF for Rotomolding Applications
by Zacks Equity Research
Celanese's (CE) Hostaform RF will offer an easy-to-use, drop-in solution for traditional rotational molding.
CE vs. DSEY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CE vs. DSEY: Which Stock Is the Better Value Option?
New to Investing? This 1 Basic Materials Stock Could Be the Perfect Starting Point
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Here's Why You Should Hold Onto Celanese (CE) Stock for Now
by Zacks Equity Research
Celanese (CE) benefits from productivity actions, investments in high-return organic projects and synergies of acquisitions.
Celanese (CE) Completes Senior Unsecured Notes Offering
by Zacks Equity Research
Celanese (CE) intends to use net proceeds from the issuance of the notes to finance the tender offer and for general corporate purposes.
Why Celanese (CE) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Celanese (CE) Gains on Productivity Actions and Acquisitions
by Zacks Equity Research
Celanese (CE) is gaining from productivity measures, investments in organic projects and strategic acquisitions.
Earnings Growth & Price Strength Make Celanese (CE) a Stock to Watch
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Celanese (CE) Completes Senior Unsecured Notes Offering
by Zacks Equity Research
Celanese (CE) plans to use net proceeds from the issuance of the Notes to repay outstanding indebtedness under its revolving credit facility.
4 Stocks to Watch From the Rebounding Chemical Specialty Industry
by Anindya Barman
The Zacks Chemicals Specialty industry is poised benefit from a rebound in global industrial and manufacturing activities. ESI, MTX, ASIX and HWKN are set to gain from demand recovery and strategic actions.
New to Investing? This 1 Basic Materials Stock Could Be the Perfect Starting Point
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
3 Chemical Stocks Likely to Outshine Q2 Earnings Estimates
by Anindya Barman
Strong end-market demand and benefits of self-help actions are likely to reflect on the Q2 performance of Westlake (WLK), DuPont (DD) and Eastman Chemical (EMN).
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks.com featured highlights include: Encompass Health, Celanese Corp, Salesforce, Ovintiv and Expeditors International of Washington
by Zacks Equity Research
Zacks.com featured highlights include: Encompass Health, Celanese Corp, Salesforce, Ovintiv and Expeditors International of Washington
5 Top Stocks With Impressive Sales Growth to Buy Right Away
by Swayta Shah
Sales growth is important for the survival of any business. Let's check Encompass Health (EHC), Celanese (CE), salesforce.com (CRM), Ovintiv (OVV) & Expeditors International (EXPD) that are likely to witness solid top-line growth.
Should You Invest in the Invesco DWA Basic Materials Momentum ETF (PYZ)?
by Zacks Equity Research
Sector ETF report for PYZ